2022 Brazil Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Database: Supplier Shares, Volume and Sales Segment Forecasts for over 40 Tests

Abstract

This database from LeadingMarketResearch.com provides the 2021 supplier shares, the 2021-2026 volume and sales forecasts for over 40 tests, as well as comprehensive lists of companies developing or marketing new technologies and products by test, including:

Blood Typing and Grouping Tests

ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s), Antiglobulin (Direct, C3 + IgG, IgG, C3), Crossmatching (Immediate Spin, Full Crossmatch), Rh (D, Du)

Infectious Disease Screening Tests

AIDS (HIV NAT, HIV-1/2), Cytomegalovirus, Hepatitis (HAV NAT, HBV NAT, HBs Ag, Anti-HBc, HCV NAT, HCV, ALT/SGPT), HTLV-I/II, Parvovirus B19 NAT, Syphilis, West Nile Virus NAT

Content
List of Tables

Executive Summary Table: Total Blood Bank
Test Volume and Reagent Sales
Forecast by Test Category
All Market Segments Blood Typing
And Grouping Test Volume Forecast
All Market Segments Infectious
Disease Screening Test Volume Forecast
All Market Segments Blood Typing
And Grouping Reagent Market
Forecast by Major Test
All Market Segments Infectious
Disease Screening Reagent Market
Forecast by Test
Major Companies Developing or Marketing
Blood Typing and Grouping Tests
Major Companies Developing or
Marketing HLA Typing Tests
Major Companies Developing or
Marketing AIDS Tests
Major Companies Developing or
Marketing Hepatitis Tests
Major Companies Developing or
Marketing CMV Tests
Major Companies Developing or
Marketing Syphilis Tests
Major Companies Developing or
Marketing Blood Bank Analyzers